220 related articles for article (PubMed ID: 35443747)
1. Novel sarbecovirus bispecific neutralizing antibodies with exceptional breadth and potency against currently circulating SARS-CoV-2 variants and sarbecoviruses.
Wang Y; Liu M; Shen Y; Ma Y; Li X; Zhang Y; Liu M; Yang XL; Chen J; Yan R; Luan D; Wang Y; Chen Y; Wang Q; Lin H; Li Y; Wu K; Zhu T; Zhao J; Lu H; Wen Y; Jiang S; Wu F; Zhou Q; Shi ZL; Huang J
Cell Discov; 2022 Apr; 8(1):36. PubMed ID: 35443747
[TBL] [Abstract][Full Text] [Related]
2. Combating the SARS-CoV-2 Omicron (BA.1) and BA.2 with potent bispecific antibodies engineered from non-Omicron neutralizing antibodies.
Wang Y; Zhang X; Ma Y; Wang Y; Zhan W; Zheng Q; Zhang M; Ji P; Liu M; Liu Q; Sun T; Zhu T; Wen Y; Sun L; Zhao J; Wu F; Chen Z; Huang J
Cell Discov; 2022 Oct; 8(1):104. PubMed ID: 36207299
[TBL] [Abstract][Full Text] [Related]
3. Broad Sarbecovirus Neutralizing Antibodies Obtained by Computational Design and Synthetic Library Screening.
Yang X; Duan H; Liu X; Zhang X; Pan S; Zhang F; Gao P; Liu B; Yang J; Chi X; Yang W
J Virol; 2023 Jul; 97(7):e0061023. PubMed ID: 37367229
[TBL] [Abstract][Full Text] [Related]
4. Targeting the Spike Receptor Binding Domain Class V Cryptic Epitope by an Antibody with Pan-Sarbecovirus Activity.
Jensen JL; Sankhala RS; Dussupt V; Bai H; Hajduczki A; Lal KG; Chang WC; Martinez EJ; Peterson CE; Golub ES; Rees PA; Mendez-Rivera L; Zemil M; Kavusak E; Mayer SV; Wieczorek L; Kannan S; Doranz BJ; Davidson E; Yang ES; Zhang Y; Chen M; Choe M; Wang L; Gromowski GD; Koup RA; Michael NL; Polonis VR; Rolland M; Modjarrad K; Krebs SJ; Joyce MG
J Virol; 2023 Jul; 97(7):e0159622. PubMed ID: 37395646
[TBL] [Abstract][Full Text] [Related]
5. Structural Study of SARS-CoV-2 Antibodies Identifies a Broad-Spectrum Antibody That Neutralizes the Omicron Variant by Disassembling the Spike Trimer.
Zhan W; Tian X; Zhang X; Xing S; Song W; Liu Q; Hao A; Hu Y; Zhang M; Ying T; Chen Z; Lan F; Sun L
J Virol; 2022 Aug; 96(16):e0048022. PubMed ID: 35924918
[TBL] [Abstract][Full Text] [Related]
6. A bispecific antibody exhibits broad neutralization against SARS-CoV-2 Omicron variants XBB.1.16, BQ.1.1 and sarbecoviruses.
Wang Y; Hao A; Ji P; Ma Y; Zhang Z; Chen J; Mao Q; Xiong X; Rehati P; Wang Y; Wang Y; Wen Y; Lu L; Chen Z; Zhao J; Wu F; Huang J; Sun L
Nat Commun; 2024 Jun; 15(1):5127. PubMed ID: 38879565
[TBL] [Abstract][Full Text] [Related]
7. Rational identification of potent and broad sarbecovirus-neutralizing antibody cocktails from SARS convalescents.
Cao Y; Jian F; Zhang Z; Yisimayi A; Hao X; Bao L; Yuan F; Yu Y; Du S; Wang J; Xiao T; Song W; Zhang Y; Liu P; An R; Wang P; Wang Y; Yang S; Niu X; Zhang Y; Gu Q; Shao F; Hu Y; Yin W; Zheng A; Wang Y; Qin C; Jin R; Xiao J; Xie XS
Cell Rep; 2022 Dec; 41(12):111845. PubMed ID: 36493787
[TBL] [Abstract][Full Text] [Related]
8. An RBD bispecific antibody effectively neutralizes a SARS-CoV-2 Omicron variant.
Yuan M; Zhu Y; Liu G; Wang Y; Wang G; Zhang G; Ye L; Qian Z; Liu P
One Health Adv; 2023; 1(1):12. PubMed ID: 37521533
[TBL] [Abstract][Full Text] [Related]
9. Characterization of cross-reactive monoclonal antibodies against SARS-CoV-1 and SARS-CoV-2: Implication for rational design and development of pan-sarbecovirus vaccines and neutralizing antibodies.
Li S; Wu J; Jiang W; He H; Zhou Y; Wu W; Gao Y; Xie M; Xia A; He J; Zhang Q; Han Y; Wang N; Zhu G; Wang Q; Zhang Z; Mayer CT; Wang K; Wang X; Wang J; Chen Z; Jiang S; Sun L; Xia R; Wang Q
J Med Virol; 2023 Feb; 95(2):e28440. PubMed ID: 36573441
[TBL] [Abstract][Full Text] [Related]
10. Targeted isolation of panels of diverse human protective broadly neutralizing antibodies against SARS-like viruses.
He WT; Musharrafieh R; Song G; Dueker K; Tse LV; Martinez DR; Schäfer A; Callaghan S; Yong P; Beutler N; Torres JL; Volk RM; Zhou P; Yuan M; Liu H; Anzanello F; Capozzola T; Parren M; Garcia E; Rawlings SA; Smith DM; Wilson IA; Safonova Y; Ward AB; Rogers TF; Baric RS; Gralinski LE; Burton DR; Andrabi R
bioRxiv; 2022 Feb; ():. PubMed ID: 35169804
[TBL] [Abstract][Full Text] [Related]
11. Broadly neutralizing and protective nanobodies against SARS-CoV-2 Omicron subvariants BA.1, BA.2, and BA.4/5 and diverse sarbecoviruses.
Li M; Ren Y; Aw ZQ; Chen B; Yang Z; Lei Y; Cheng L; Liang Q; Hong J; Yang Y; Chen J; Wong YH; Wei J; Shan S; Zhang S; Ge J; Wang R; Dong JZ; Chen Y; Shi X; Zhang Q; Zhang Z; Chu JJH; Wang X; Zhang L
Nat Commun; 2022 Dec; 13(1):7957. PubMed ID: 36575191
[TBL] [Abstract][Full Text] [Related]
12. Identification of a broad sarbecovirus neutralizing antibody targeting a conserved epitope on the receptor-binding domain.
Wang Y; Zhang Z; Yang M; Xiong X; Yan Q; Cao L; Wei P; Zhang Y; Zhang L; Lv K; Chen J; Liu X; Zhao X; Xiao J; Zhang S; Zhu A; Gan M; Zhang J; Cai R; Zhuo J; Zhang Y; Rao H; Qu B; Zhang Y; Chen L; Dai J; Cheng L; Hu Q; Chen Y; Lv H; So RTY; Peiris M; Zhao J; Liu X; Mok CKP; Wang X; Zhao J
Cell Rep; 2024 Jan; 43(1):113653. PubMed ID: 38175758
[TBL] [Abstract][Full Text] [Related]
13. Extremely potent pan-sarbecovirus neutralizing antibodies generated by immunization of macaques with an AS03-adjuvanted monovalent subunit vaccine against SARS-CoV-2.
Feng Y; Yuan M; Powers JM; Hu M; Munt JE; Arunachalam PS; Leist SR; Bellusci L; Adams LE; Sundaramurthy S; Shirreff LM; Mallory ML; Scooby TD; Moreno A; O'Hagan DT; Kleanthous H; Villinger FJ; Veesler D; King NP; Suthar MS; Khurana S; Baric RS; Wilson IA; Pulendran B
bioRxiv; 2023 Jan; ():. PubMed ID: 36711543
[TBL] [Abstract][Full Text] [Related]
14. Potent pan huACE2-dependent sarbecovirus neutralizing monoclonal antibodies isolated from a BNT162b2-vaccinated SARS survivor.
Chia WN; Tan CW; Tan AWK; Young B; Starr TN; Lopez E; Fibriansah G; Barr J; Cheng S; Yeoh AY; Yap WC; Lim BL; Ng TS; Sia WR; Zhu F; Chen S; Zhang J; Kwek MSS; Greaney AJ; Chen M; Au GG; Paradkar PN; Peiris M; Chung AW; Bloom JD; Lye D; Lok S; Wang LF
Sci Adv; 2023 Jul; 9(30):eade3470. PubMed ID: 37494438
[TBL] [Abstract][Full Text] [Related]
15. Development of variant-proof severe acute respiratory syndrome coronavirus 2, pan-sarbecovirus, and pan-β-coronavirus vaccines.
Zhou J; Liu Z; Zhang G; Xu W; Xing L; Lu L; Wang Q; Jiang S
J Med Virol; 2023 Jan; 95(1):e28172. PubMed ID: 36161303
[TBL] [Abstract][Full Text] [Related]
16. A monoclonal antibody that neutralizes SARS-CoV-2 variants, SARS-CoV, and other sarbecoviruses.
Wang P; Casner RG; Nair MS; Yu J; Guo Y; Wang M; Chan JF; Cerutti G; Iketani S; Liu L; Sheng Z; Chen Z; Yuen KY; Kwong PD; Huang Y; Shapiro L; Ho DD
bioRxiv; 2021 Oct; ():. PubMed ID: 34671769
[TBL] [Abstract][Full Text] [Related]
17. Nasal delivery of broadly neutralizing antibodies protects mice from lethal challenge with SARS-CoV-2 delta and omicron variants.
Lu J; Yin Q; Pei R; Zhang Q; Qu Y; Pan Y; Sun L; Gao D; Liang C; Yang J; Wu W; Li J; Cui Z; Wang Z; Li X; Li D; Wang S; Duan K; Guan W; Liang M; Yang X
Virol Sin; 2022 Apr; 37(2):238-247. PubMed ID: 35527227
[TBL] [Abstract][Full Text] [Related]
18. Broadly neutralizing antibody induction by non-stabilized SARS-CoV-2 Spike mRNA vaccination in nonhuman primates.
Malewana RD; Stalls V; May A; Lu X; Martinez DR; Schäfer A; Li D; Barr M; Sutherland LL; Lee E; Parks R; Beck WE; Newman A; Bock KW; Minai M; Nagata BM; DeMarco CT; Denny TN; Oguin TH; Rountree W; Wang Y; Mansouri K; Edwards RJ; Sempowski GD; Eaton A; Muramatsu H; Henderson R; Tam Y; Barbosa C; Tang J; Cain DW; Santra S; Moore IN; Andersen H; Lewis MG; Golding H; Seder R; Khurana S; Montefiori DC; Pardi N; Weissman D; Baric RS; Acharya P; Haynes BF; Saunders KO
bioRxiv; 2023 Dec; ():. PubMed ID: 38187726
[TBL] [Abstract][Full Text] [Related]
19. Targeted isolation of diverse human protective broadly neutralizing antibodies against SARS-like viruses.
He WT; Musharrafieh R; Song G; Dueker K; Tse LV; Martinez DR; Schäfer A; Callaghan S; Yong P; Beutler N; Torres JL; Volk RM; Zhou P; Yuan M; Liu H; Anzanello F; Capozzola T; Parren M; Garcia E; Rawlings SA; Smith DM; Wilson IA; Safonova Y; Ward AB; Rogers TF; Baric RS; Gralinski LE; Burton DR; Andrabi R
Nat Immunol; 2022 Jun; 23(6):960-970. PubMed ID: 35654851
[TBL] [Abstract][Full Text] [Related]
20. Pan-sarbecovirus prophylaxis with human anti-ACE2 monoclonal antibodies.
Zhang F; Jenkins J; de Carvalho RVH; Nakandakari-Higa S; Chen T; Abernathy ME; Baharani VA; Nyakatura EK; Andrew D; Lebedeva IV; Lorenz IC; Hoffmann HH; Rice CM; Victora GD; Barnes CO; Hatziioannou T; Bieniasz PD
Nat Microbiol; 2023 Jun; 8(6):1051-1063. PubMed ID: 37188812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
